Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
08:15am, Thursday, 22'nd May 2025
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Buy 9 Barron's Better Bets (Than T-Bills) From 16 'Safer' May Dividend Dogs
04:20pm, Wednesday, 21'st May 2025
Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge d
Pfizer Looks Like A Great Play At Current Valuations
12:20pm, Wednesday, 21'st May 2025
Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals versus peers. The company leads its peer group in EBITDA and revenue growth,
MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots
09:41am, Wednesday, 21'st May 2025
Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and BioNTech stocks.
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
08:00am, Wednesday, 21'st May 2025
No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 to Russia Company plans to export PCV13 vaccine components "We aim for the g
2 High-Yield Dividend Stocks to Buy Right Now
06:23am, Wednesday, 21'st May 2025
Though there are plenty of dividend stocks on the market, they aren't all created equal. Consider that the average dividend yield for the S&P 500 (^GSPC -0.39%) is 1.3%, which is not particularly high
Pfizer Pacing for 4th Day of Gains
01:35pm, Tuesday, 20'th May 2025
Pfizer closes a deal on a new Cancer drug. The stock is pacing for 4th day of gains.
Pfizer Thinks Bigger With 3SBio Deal
11:46am, Tuesday, 20'th May 2025
Pfizer Inc. decided to think bigger after the Summit deal in February and that it needs control of a PD-1/VEGF bispecific antibody versus participating with its ADC pipeline. The 3SBio deal allows inc
Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China
10:01am, Tuesday, 20'th May 2025
Pfizer (PFE) has announced a new agreement to develop and market a cancer drug currently being developed by Chinese drugmaker 3SBio.
Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside Potential
10:01am, Tuesday, 20'th May 2025
Three Wide Mode stocks with strong short-term upsides are: PFE, KO, DIS.
Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech
09:51am, Tuesday, 20'th May 2025
PFE in-licenses global rights, ex-China, to SSGJ-707, from Chinese biotech, 3SBio for an upfront payment of $1.25 billion.
Pfizer strikes deal with China's 3SBio to license cancer drug
08:51am, Tuesday, 20'th May 2025
CNBC's Angelica Peebles joins 'Squawk Box' to report on the latest news.
Pfizer Signs Experimental Drug Licensing Agreement With 3SBio
07:31am, Tuesday, 20'th May 2025
Pfizer inks Experimental Drug Licensing Deal With China-based company 3SBio.
4 Blue-Chip Stocks With Huge Dividends at 52-Week Lows Are Table-Pounding Buys
07:18am, Tuesday, 20'th May 2025
The trend is your friend is a well-known Wall Street catchphrase that often has proven to be correct.
These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe
03:50am, Tuesday, 20'th May 2025
If you see a stock that pays 6% in dividends, you might assume it's too risky -- but that's not always the case. In some situations, a yield can grow to such heights because investors have been dumpin
